BACKGROUND: Menière's Disease (MD) is a debilitating disorder with episodic and variable ear symptoms. Diagnosis can be challenging and evidence for a psychometric instrument to assess subjective impairment of hearing and the associated burden in daily life is currently lacking. OBJECTIVE: To evaluate a short form of the Speech, Spatial und Qualities of Hearing Scale (SSQ) for hearing-related disability in MD. METHODS: Data was collected from a multicenter prospective patient registry for long-term follow up of MD-patients. Hearing was assessed by pure tone and speech audiometry. The SSQ was applied in a version with 17 items. RESULTS: 97 consecutive patients with unilateral MD had a mean age of 56.2 +/- 5.0 years. 55 individuals (57.3%) were female, 72 (75.0%) were categorized as definite MD. Average total score of the SSQ was 6.0 +/- 2.1. Cronbach's alpha for internal consistency was 0.960 for the total score. We did not observe undue floor or ceiling effects. SSQ values showed a negative correlation with hearing thresholds and a positive correlation with speech recognition scores. CONCLUSIONS: The short form of the SSQ is a good option to provide insight into hearing-specific disability in patients with MD.

The authors have declared no competing interest.

https://drks.de/search/de/trial/DRKS00027830

This study did not receive any funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committees/IRBs of the Faculty of Medicine of LMU Munich and of Greifswald University Medicine gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.